document.write('<link href=\"http://hosted2.ap.org/css/ComponentTypes/Headlines.css\" rel=\"Stylesheet\" type=\"text/css\" />');
document.write('');
document.write('<script type=\"text/javascript\" language=\"javascript\">');
document.write('var localScriptObj = document.createElement(\"script\");localScriptObj.setAttribute(\"type\", \"text/javascript\");localScriptObj.setAttribute(\"charset\", \"utf-8\");localScriptObj.setAttribute(\"src\", \"http://hosted2.ap.org/scripts/dynamicScript.js\");var thisheadLoc = document.getElementsByTagName(\"head\").item(0);thisheadLoc.appendChild(localScriptObj);');
document.write('</script>');
document.write('');
document.write('<script type=\"text/javascript\" language=\"javascript\">');
document.write('var localScriptObj = document.createElement(\"script\");localScriptObj.setAttribute(\"type\", \"text/javascript\");localScriptObj.setAttribute(\"charset\", \"utf-8\");localScriptObj.setAttribute(\"src\", \"http://hosted2.ap.org/scripts/cookies.js\");var thisheadLoc = document.getElementsByTagName(\"head\").item(0);thisheadLoc.appendChild(localScriptObj);');
document.write('</script>');
document.write('<link href=\"http://hosted2.ap.org/css/Hosted.css\" rel=\"Stylesheet\" type=\"text/css\" />');
document.write('<style type=\"text/css\">.apm038fd3776b0143d09f423027feb5d1e5{}');
document.write('');
document.write('');
document.write('.hdl_combo-038fd3776b0143d09f423027feb5d1e5 .ap_hdr-038fd3776b0143d09f423027feb5d1e5 {display: none; }');
document.write('');
document.write('.hdl_combo-038fd3776b0143d09f423027feb5d1e5, .hdl_combo-038fd3776b0143d09f423027feb5d1e5 .ap_hdr-038fd3776b0143d09f423027feb5d1e5 {border-style: solid;border-width: 2px;border-color: #fff; }');
document.write('');
document.write('.hdl_combo .ap_hdr-038fd3776b0143d09f423027feb5d1e5 {background:none; background-color: #fff;line-height: 24px;font-family: Arial;color: #FFFFFF;font-size: 11px;text-transform: capitalize;font-weight: bold;border-top: 0px; border-right: 0px; border-left: 0px; }');
document.write('');
document.write('.hdl_combo .ap_blk_hd-038fd3776b0143d09f423027feb5d1e5, .hdl_combo-038fd3776b0143d09f423027feb5d1e5 li a {font-family: Arial;color: #999999;font-size: 11px;font-weight: bold;text-decoration: none; }');
document.write('');
document.write('.hdl_combo .ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5, .hdl_combo-038fd3776b0143d09f423027feb5d1e5 li a {font-family: Verdana;color: #556677;font-size: 14px;text-transform: none;font-weight: bold;text-decoration: none; }');
document.write('');
document.write('.hdl_combo-038fd3776b0143d09f423027feb5d1e5 li a:hover {color: #CC3300; }');
document.write('');
document.write('.hdl_combo .ap_dt_stmp-038fd3776b0143d09f423027feb5d1e5 {font-family: Arial;color: #999999;font-size: 11px;font-style: Normal; font-weight: normal; }');
document.write('');
document.write('.hdl_combo .ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5 {font-family: Verdana;color: #999999;font-size: 11px;text-transform: none;font-style: Normal; font-weight: normal; }');
document.write('');
document.write('.hdl_combo .ap_tm_stmp-038fd3776b0143d09f423027feb5d1e5 {font-family: Arial;color: #999999;font-size: 11px;font-style: Normal; font-weight: normal; }');
document.write('');
document.write('.hdl_combo .ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5 {font-family: Verdana;color: #999999;font-size: 11px;text-transform: none;font-style: Normal; font-weight: normal; }');
document.write('');
document.write('.hdl_combo .ap_aud_icn-038fd3776b0143d09f423027feb5d1e5 {background:url(http://hosted2.ap.org/images/audioIcon.gif) left no-repeat; }');
document.write('');
document.write('.hdl_combo .ap_aud_icn-038fd3776b0143d09f423027feb5d1e5:hover {background:url(http://hosted2.ap.org/images/audioIconHover.gif) left no-repeat; }');
document.write('');
document.write('.hdl_combo .ap_vid_icn-038fd3776b0143d09f423027feb5d1e5 {background:url(http://hosted2.ap.org/images/videoIcon.gif) left no-repeat; }');
document.write('');
document.write('.hdl_combo .ap_vid_icn-038fd3776b0143d09f423027feb5d1e5:hover {background:url(http://hosted2.ap.org/images/videoIconHover.gif) left no-repeat; }');
document.write('');
document.write('.hdl_combo .ap_pic_icn-038fd3776b0143d09f423027feb5d1e5 {background:url(http://hosted2.ap.org/images/photosIcon.gif) left no-repeat; }');
document.write('');
document.write('.hdl_combo .ap_pic_icn-038fd3776b0143d09f423027feb5d1e5:hover {background:url(http://hosted2.ap.org/images/photosIconHover.gif) left no-repeat; }');
document.write('');
document.write('.hdl_combo .ap_icn_ttl-038fd3776b0143d09f423027feb5d1e5 {font-family: Arial;color: #556677;font-size: 11px;font-style: Normal; font-weight: normal;text-decoration: none;display: inline; }');
document.write('');
document.write('.hdl_combo .ap_icn_ttl-038fd3776b0143d09f423027feb5d1e5 a:hover {color: #CC3300; }');
document.write('');
document.write('.hdl_combo .ap_mlt_lnk-038fd3776b0143d09f423027feb5d1e5 {display: inline; }');
document.write('');
document.write('.hdl_combo .ap_slg_txt-038fd3776b0143d09f423027feb5d1e5 {font-family: Arial;color: #000000;font-size: 11px;font-style: Normal; font-weight: normal; }');
document.write('');
document.write('.hdl_combo-038fd3776b0143d09f423027feb5d1e5 li {border-style: solid;border-color: #fff;border-width: 2px; border-top: 0px; border-right: 0px; border-left: 0px;clear: both; padding: 5px 3px 3px 0px; margin: 0px; list-style: none; }');
document.write('');
document.write('.hdl_combo .ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5 {padding:0px 0px 0px 5px; }');
document.write('');
document.write('.hdl_combo .ap_cnt_area-038fd3776b0143d09f423027feb5d1e5 {padding-left: 0px;background-color: #FFFFFF; display:inline-block; }');
document.write('');
document.write('.hdl_combo .ap_blt_on-038fd3776b0143d09f423027feb5d1e5 li {list-style: url(http://hosted2.ap.org/images/bult.gif); }');
document.write('');
document.write('.hdl_combo .ap_li_end-038fd3776b0143d09f423027feb5d1e5 {padding-bottom: 0px; }');
document.write('');
document.write('');
document.write('');
document.write('</style></head><body>');
document.write('<script type=\"text/javascript\" language=\"javascript\">');
eval("var updateHeadlines4a7fe7c8103b46e9875b13e1a2e222f2 = function() { dynamicRefresh('http://hosted2.ap.org/json/KTNFAM/038fd3776b0143d09f423027feb5d1e5/uid-4a7fe7c8103b46e9875b13e1a2e222f2', 120000, '', '4a7fe7c8103b46e9875b13e1a2e222f2'); }");
document.write('');
eval("setTimeout('updateHeadlines4a7fe7c8103b46e9875b13e1a2e222f2()', 120000);");
document.write('</script>');
document.write('<div id=\"divhdl_comboe10d7f70f2294c0ca1d506a0107c3ab0\">');
document.write('');
document.write('<div class=\"hdl_combo hdl_combo-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<div class=\"ap_hdr ap_hdr-038fd3776b0143d09f423027feb5d1e5\" style=\"width:100%; display:none\">Health</div>');
document.write('');
document.write('<ul class=\"ap_cnt_area ap_cnt_area-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_img_lnk\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-FBN-Packers-Injuries/id-pb55636882903407baad436d9dccc1248\">');
document.write('');
document.write('<img src=\"http://hosted2.ap.org/CBImages/?media=photo&amp;contentId=14d2b96b8547406aa190f299cda7577f&amp;fmt=jpg&amp;Role=Thumbnail&amp;reldt=2009-11-22T22:02:06GMT&amp;authToken=eNoFwrkNwCAMAMCJjPwbFwzDEyS6lCkYPrq7z9dcJNXRkhURLVjuPI108UgfUE0DFL1Dp0TYnDlXD4vY97ytFspCqkX8BwUeE6I%3d\" alt=\"Click for Full Story\" width=\"128\" height=\"100\" />');
document.write('');
document.write('</a>');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-FBN-Packers-Injuries/id-pb55636882903407baad436d9dccc1248\">Harris, Kampman lost for season with knee injuries</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">GREEN BAY, Wis. (AP) — The Green Bay Packers feared the worst after watching two of their top defensive players get carted to the locker room Sunday, and things didn\'t look any better the next morning. Cornerback Al Harris and linebacker Aaron Kampman will both have season-ending knee surgery.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-US-Skilled-Healthcare-Group-Personnel/id-p92180d8cff3241bca3bc2f3c926e77ee\">Skilled Healthcare names Rosenstock to board</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">FOOTHILL RANCH, Calif. (AP) — Nursing facility operator Skilled Healthcare Group Inc. said Monday it named Dr. Linda Rosenstock to the company\'s board of directors.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-EU-Belgium-Coma-Recovery/id-p4b5b2c634c4e4c7b99b676efad1b16c9\">Mom: Son in coma heard everything for 23 years</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">BRUSSELS (AP) — A man who emerged from what doctors thought was a vegetative state says he was fully conscious for 23 years but could not respond because he was paralyzed, his mother said Monday.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_img_lnk\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-US-Senate-Leaders/id-p48976760ba9e429ea0ebd0fc56671d38\">');
document.write('');
document.write('<img src=\"http://hosted2.ap.org/CBImages/?media=photo&amp;contentId=71e5f7340d1d44a894274ad84e5c245e&amp;fmt=jpg&amp;Role=Thumbnail&amp;reldt=2009-11-22T02:33:14GMT&amp;authToken=eNoFwrsNwCAMBcCJjPx5BlwwDAJHokuZguGju5vfqGaByh7qzNxV2l1nNEl%2fmoF4yyZgdgpoI8zdkb4Unve8oxeJIkCx%2bgMGexOe\" alt=\"Click for Full Story\" width=\"128\" height=\"89\" />');
document.write('');
document.write('</a>');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-US-Senate-Leaders/id-p48976760ba9e429ea0ebd0fc56671d38\">For Reid, Dodd, clout on big issues cuts both ways</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">WASHINGTON (AP) — Two Senate leaders trying to steer a pair of President Barack Obama\'s high-stakes initiatives through Congress are being dogged by re-election worries, and it\'s not clear whether their legislative prominence will help or hurt them.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_img_lnk\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-FBN-Battered-Redskins/id-p808a9595cb294403bee25df59c631661\">');
document.write('');
document.write('<img src=\"http://hosted2.ap.org/CBImages/?media=photo&amp;contentId=f6607e4d79344212bb0d0dbf38598648&amp;fmt=jpg&amp;Role=Thumbnail&amp;reldt=2009-11-22T23:23:56GMT&amp;authToken=eNoFwrENwCAMBMCJjB78GLtgGQJIdClTMHx0d9fXTTVoqFEqANJ4n9O3GdrilBZKYclFxsAUzLHVa7jR73m7pxwpk0ntBwSWE3M%3d\" alt=\"Click for Full Story\" width=\"128\" height=\"114\" />');
document.write('');
document.write('</a>');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-FBN-Battered-Redskins/id-p808a9595cb294403bee25df59c631661\">Redskins\' RB Betts, G Rinehart out for the season</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">ASHBURN, Va. (AP) — Running back Ladell Betts and guard Chad Rinehart are done for the season for the battered Washington Redskins.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-US-Pharmasset-Hepatitis-C/id-pdead1534c4114c5e86bdb29d63606b75\">Pharmasset: hepatitis C drug trial will continue</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">NEW YORK (AP) — Pharmasset Inc. said Monday that it will continue enrolling patients in a clinical trial of RG7128, a drug that is designed to treat the liver disease hepatitis C.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-US-GlaxoSmithKline-Prostate-Drug/id-p916206554c844005b98c44c44e668cdc\">GlaxoSmithKline pulls application for new drug use</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">TRENTON, N.J. (AP) — British drugmaker GlaxoSmithKline PLC said Monday it is temporarily withdrawing its application for U.S. approval of a drug to prevent prostate cancer.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-US-WellPoint-Mover/id-p456144416bb940ee91df04007771f8d6\">Cigna, WellPoint upgraded on costs, reform details</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">NEW YORK (AP) — An analyst for JPMorgan upgraded shares of WellPoint Inc. and Cigna Corp. Monday, saying the stocks should trade higher as the details of a federal health care reform bill come into focus.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-US-Medtronic-Earnings-Preview/id-p05af3bf3294d456dac03a5dbdfbbcf98\">Earnings Preview: Medtronic</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">WASHINGTON (AP) — Medtronic, the world\'s largest medical device maker, reports earnings for the second fiscal quarter of 2010 on Tuesday. The following is a summary of key developments and analyst opinion for the last period.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-US-Rigel-Mover/id-pbc54a6f5a5894562a71eee36feff390e\">Rigel shares rise on RBC analyst upgrade</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">NEW YORK (AP) — Rigel Pharmaceuticals Inc. rose after an RBC Capital Markets analyst recommended buying shares of the drug developer based on his expectations the company will announce news of a partnership for a key drug candidate.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_v_img_lnk\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-HKN-Blue-Jackets-Moves/id-p456f4a30ed6b408db4a213e489267b34\">');
document.write('');
document.write('<img src=\"http://hosted2.ap.org/CBImages/?media=photo&amp;contentId=7b084eb030f947e091a1c34471de1909&amp;fmt=jpg&amp;Role=Thumbnail&amp;reldt=2009-11-20T03:17:57GMT&amp;authToken=eNoFwjkOwCAMBMAXGa3xcrjgMYE4El3KFDw%2bmjnxjWrmrCieCwDLKGft0SY6Y0IMjwtbQFwvlWVk0zvU4We%2foyf1pGSy%2bgMB0BNa\" alt=\"Click for Full Story\" width=\"112\" height=\"128\" />');
document.write('');
document.write('</a>');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-HKN-Blue-Jackets-Moves/id-p456f4a30ed6b408db4a213e489267b34\">Blue Jackets F Dorsett on IR after Neal boarding</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">COLUMBUS, Ohio (AP) — The Columbus Blue Jackets have placed forward Derek Dorsett on injured reserve retroactive to Thursday.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-US-Bristol-Myers-Asterand/id-p8247a284937b48f187b839c7015ad07b\">Bristol-Myers extends partnership with Asterand</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">NEW YORK (AP) — Drugmaker Bristol-Myers Squibb Co. and Asterand PLC are extending a research collaboration for up to three years, Asterand said Monday.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-US-Pfizer-Cattle-Vaccines/id-p39fcce662ccc4e1493173fb93a83e2c8\">Pfizer, Immunovaccine in animal vaccine deal</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">NEW YORK (AP) — Immunovaccine Inc. said Monday that Pfizer Inc., the world\'s largest drugmaker, is licensing its technology for use in vaccines for cattle.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-US-Raptor-Pharmaceutical-Study/id-p31b61e253d2043cb87085423beccb6d2\">Raptor\'s genetic disorder drug meets study goals</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">NOVATO, Calif. (AP) — Raptor Pharmaceutical Corp. said Monday its developing treatment for the genetic disorder nephropathic cystinosis met key goals in a midstage study.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li class=\"ap_li_end ap_li_end-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-US-Health-Care-Briefing/id-pdac815bfefe648b4b5d27a2d31a29cf1\">Health care issues: What are GOP\'s reform ideas?</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">A look at key issues in the health care debate:</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('</ul>');
document.write('');
document.write('</div>');
document.write('');
document.write('</div>');
document.write('</body></html>');